6-bromo-2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazoline;tert-butyl N-[(3R)-1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-yl]carbamate;tert-butyl N-[(3R)-pyrrolidin-3-yl]carbamate;(3R)-1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]-N,N-dimethylpyrrolidin-3-amine;(3R)-1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-amine

C120H153BrN20O8 — CID 158491247

IUPAC6-bromo-2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazoline;tert-butyl N-[(3R)-1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-yl]carbamate;tert-butyl N-[(3R)-pyrrolidin-3-yl]carbamate;(3R)-1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]-N,N-dimethylpyrrolidin-3-amine;(3R)-1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-amine
SMILESCC(C)(C)OC(=O)N[C@@H]1CCNC1.COc1ccccc1C1CCN(c2nc(C3CC3)nc3ccc(Br)cc23)CC1.COc1ccccc1C1CCN(c2nc(C3CC3)nc3ccc(N4CC[C@@H](N(C)C)C4)cc23)CC1.COc1ccccc1C1CCN(c2nc(C3CC3)nc3ccc(N4CC[C@@H](N)C4)cc23)CC1.COc1ccccc1C1CCN(c2nc(C3CC3)nc3ccc(N4CC[C@@H](NC(=O)OC(C)(C)C)C4)cc23)CC1
InChIInChI=1S/C32H41N5O3.C29H37N5O.C27H33N5O.C23H24BrN3O.C9H18N2O2/c1-32(2,3)40-31(38)33-23-15-18-37(20-23)24-11-12-27-26(19-24)30(35-29(34-27)22-9-10-22)36-16-13-21(14-17-36)25-7-5-6-8-28(25)39-4;1-32(2)23-14-17-34(19-23)22-10-11-26-25(18-22)29(31-28(30-26)21-8-9-21)33-15-12-20(13-16-33)24-6-4-5-7-27(24)35-3;1-33-25-5-3-2-4-22(25)18-10-13-31(14-11-18)27-23-16-21(32-15-12-20(28)17-32)8-9-24(23)29-26(30-27)19-6-7-19;1-28-21-5-3-2-4-18(21)15-10-12-27(13-11-15)23-19-14-17(24)8-9-20(19)25-22(26-23)16-6-7-16;1-9(2,3)13-8(12)11-7-4-5-10-6-7/h5-8,11-12,19,21-23H,9-10,13-18,20H2,1-4H3,(H,33,38);4-7,10-11,18,20-21,23H,8-9,12-17,19H2,1-3H3;2-5,8-9,16,18-20H,6-7,10-15,17,28H2,1H3;2-5,8-9,14-16H,6-7,10-13H2,1H3;7,10H,4-6H2,1-3H3,(H,11,12)/t2*23-;20-;;7-/m111.1/s1
InChIKeyHISKHXLFSPAPOS-ZHYCBDGJSA-N
MW2083.58 g/mol
LogP22.02
Rot. Bonds22

About 6-bromo-2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazoline;tert-butyl N-[(3R)-1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-yl]carbamate;tert-butyl N-[(3R)-pyrrolidin-3-yl]carbamate;(3R)-1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]-N,N-dimethylpyrrolidin-3-amine;(3R)-1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-amine

6-bromo-2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazoline;tert-butyl N-[(3R)-1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-yl]carbamate;tert-butyl N-[(3R)-pyrrolidin-3-yl]carbamate;(3R)-1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]-N,N-dimethylpyrrolidin-3-amine;(3R)-1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-amine (PubChem CID 158491247) has the molecular formula C120H153BrN20O8 and a molecular weight of 2083.58 g/mol. Its IUPAC name is 6-bromo-2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazoline;tert-butyl N-[(3R)-1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-yl]carbamate;tert-butyl N-[(3R)-pyrrolidin-3-yl]carbamate;(3R)-1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]-N,N-dimethylpyrrolidin-3-amine;(3R)-1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-amine.

Molecular Properties

Compound Name6-bromo-2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazoline;tert-butyl N-[(3R)-1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-yl]carbamate;tert-butyl N-[(3R)-pyrrolidin-3-yl]carbamate;(3R)-1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]-N,N-dimethylpyrrolidin-3-amine;(3R)-1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-amine
PubChem CID158491247
Molecular FormulaC120H153BrN20O8
Molecular Weight2083.58 g/mol
Exact Mass2081.14
IUPAC Name6-bromo-2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazoline;tert-butyl N-[(3R)-1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-yl]carbamate;tert-butyl N-[(3R)-pyrrolidin-3-yl]carbamate;(3R)-1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]-N,N-dimethylpyrrolidin-3-amine;(3R)-1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-amine
SMILESCC(C)(C)OC(=O)N[C@@H]1CCNC1.COc1ccccc1C1CCN(c2nc(C3CC3)nc3ccc(Br)cc23)CC1.COc1ccccc1C1CCN(c2nc(C3CC3)nc3ccc(N4CC[C@@H](N(C)C)C4)cc23)CC1.COc1ccccc1C1CCN(c2nc(C3CC3)nc3ccc(N4CC[C@@H](N)C4)cc23)CC1.COc1ccccc1C1CCN(c2nc(C3CC3)nc3ccc(N4CC[C@@H](NC(=O)OC(C)(C)C)C4)cc23)CC1
InChIInChI=1S/C32H41N5O3.C29H37N5O.C27H33N5O.C23H24BrN3O.C9H18N2O2/c1-32(2,3)40-31(38)33-23-15-18-37(20-23)24-11-12-27-26(19-24)30(35-29(34-27)22-9-10-22)36-16-13-21(14-17-36)25-7-5-6-8-28(25)39-4;1-32(2)23-14-17-34(19-23)22-10-11-26-25(18-22)29(31-28(30-26)21-8-9-21)33-15-12-20(13-16-33)24-6-4-5-7-27(24)35-3;1-33-25-5-3-2-4-22(25)18-10-13-31(14-11-18)27-23-16-21(32-15-12-20(28)17-32)8-9-24(23)29-26(30-27)19-6-7-19;1-28-21-5-3-2-4-18(21)15-10-12-27(13-11-15)23-19-14-17(24)8-9-20(19)25-22(26-23)16-6-7-16;1-9(2,3)13-8(12)11-7-4-5-10-6-7/h5-8,11-12,19,21-23H,9-10,13-18,20H2,1-4H3,(H,33,38);4-7,10-11,18,20-21,23H,8-9,12-17,19H2,1-3H3;2-5,8-9,16,18-20H,6-7,10-15,17,28H2,1H3;2-5,8-9,14-16H,6-7,10-13H2,1H3;7,10H,4-6H2,1-3H3,(H,11,12)/t2*23-;20-;;7-/m111.1/s1
InChIKeyHISKHXLFSPAPOS-ZHYCBDGJSA-N
XLogP22.02
TPSA280.67 Ų
H-Bond Donors4
H-Bond Acceptors26
Rotatable Bonds22
Heavy Atoms149
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002083.58
LogP ≤ 522.02
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1026

Analyze 6-bromo-2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazoline;tert-butyl N-[(3R)-1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-yl]carbamate;tert-butyl N-[(3R)-pyrrolidin-3-yl]carbamate;(3R)-1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]-N,N-dimethylpyrrolidin-3-amine;(3R)-1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

bis(carbon dioxide);1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]-N,N-dimethylpyrrolidin-3-amine;(3R)-1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]-N,N-dimethylpyrrolidin-3-amine;(3S)-1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]-N,N-dimethylpyrrolidin-3-amine;1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]-N,N-dipropylpiperidin-4-amine
CID 157329044
6-bromo-4-[4-(2-methoxyphenyl)piperidin-1-yl]-2-(1-methylcyclopropyl)quinazoline;methane;4-[4-(2-methoxyphenyl)piperidin-1-yl]-2-(1-methylcyclopropyl)-N-(2-morpholin-4-ylethyl)quinazolin-6-amine;4-[4-(2-methoxyphenyl)piperidin-1-yl]-N-methyl-2-(1-methylcyclopropyl)-N-(2-morpholin-4-ylethyl)quinazolin-6-amine
CID 157957886
acetic acid;6-bromo-2-cyclopropyl-3H-quinazolin-4-one;(3R)-1-(6-bromo-2-cyclopropylquinazolin-4-yl)-N-(2-methoxyphenyl)pyrrolidin-3-amine;1-bromo-2-methoxybenzene;tert-butyl (3S)-3-aminopyrrolidine-1-carboxylate;tert-butyl N-[(3R)-1-(6-bromo-2-cyclopropylquinazolin-4-yl)pyrrolidin-3-yl]-N-(2-methoxyphenyl)carbamate;tert-butyl N-[(3R)-1-[2-cyclopropyl-6-[methyl(propyl)amino]quinazolin-4-yl]pyrrolidin-3-yl]-N-(2-methoxyphenyl)carbamate;tert-butyl (3S)-3-[(2-methoxyphenyl)methyl]pyrrolidine-1-carboxylate;tert-butyl (2-methylpropan-2-yl)oxycarbonyl carbonate;2-[[2-cyclopropyl-4-[(3R)-3-(2-methoxyanilino)pyrrolidin-1-yl]quinazolin-6-yl]-methylamino]ethanol;methane;(3S)-3-[(2-methoxyphenyl)methyl]pyrrolidine;palladium
CID 158472288
6-bromo-4-[4-(2-methoxyphenyl)piperidin-1-yl]-2-(1-methylcyclopropyl)quinazoline;N-[2-[tert-butyl(dimethyl)silyl]oxyethyl]-4-[4-(2-methoxyphenyl)piperidin-1-yl]-2-(1-methylcyclopropyl)quinazolin-6-amine;2-[[4-[4-(2-methoxyphenyl)piperidin-1-yl]-2-(1-methylcyclopropyl)quinazolin-6-yl]-methylamino]ethanol;4-[4-(2-methoxyphenyl)piperidin-1-yl]-N-methyl-2-(1-methylcyclopropyl)-N-propylquinazolin-6-amine
CID 158821475
bis(carbon dioxide);(3R)-1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]-N,N-dimethylpyrrolidin-3-amine;(3S)-1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]-N,N-dimethylpyrrolidin-3-amine;1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]-N,N-dipropylpiperidin-4-amine;ethyl 2-[[1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]piperidin-4-yl]-methylamino]acetate
CID 158865432
acetic acid;6-bromo-2-cyclopropyl-3H-quinazolin-4-one;(3R)-1-(6-bromo-2-cyclopropylquinazolin-4-yl)-N-(2-methoxyphenyl)pyrrolidin-3-amine;1-bromo-2-methoxybenzene;tert-butyl (3S)-3-aminopyrrolidine-1-carboxylate;tert-butyl N-[(3R)-1-(6-bromo-2-cyclopropylquinazolin-4-yl)pyrrolidin-3-yl]-N-(2-methoxyphenyl)carbamate;tert-butyl N-[(3R)-1-[2-cyclopropyl-6-[methyl(propyl)amino]quinazolin-4-yl]pyrrolidin-3-yl]-N-(2-methoxyphenyl)carbamate;tert-butyl (3S)-3-[(2-methoxyphenyl)methyl]pyrrolidine-1-carboxylate;tert-butyl (2-methylpropan-2-yl)oxycarbonyl carbonate;methane;(3S)-3-[(2-methoxyphenyl)methyl]pyrrolidine;palladium
CID 158948777
sodium;6-bromo-2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazoline;tert-butyl-dimethyl-[(3S)-pyrrolidin-3-yl]oxysilane;2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]-6-[(3S)-3-methoxypyrrolidin-1-yl]quinazoline;2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]-6-[(3S)-3-methylpyrrolidin-1-yl]quinazoline;(3S)-1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-ol;hydride;hydroperoxy-hydroxy-dimethyl-oxo-lambda6-sulfane;methanol;(3S)-pyrrolidin-3-ol
CID 161160726
6-bromo-2-(1-fluorocyclopropyl)-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazoline;tert-butyl-dimethyl-[(3S)-pyrrolidin-3-yl]oxysilane;2-(1-fluorocyclopropyl)-4-[4-(2-methoxyphenyl)piperidin-1-yl]-6-[(3S)-3-methylpyrrolidin-1-yl]quinazoline;(3S)-1-[2-(1-fluorocyclopropyl)-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-ol;methanol;sulfane
CID 161806764
6-bromo-4-[4-(2-methoxyphenyl)piperidin-1-yl]-2-(1-methylcyclopropyl)quinazoline;N-[2-[tert-butyl(dimethyl)silyl]oxyethyl]-4-[4-(2-methoxyphenyl)piperidin-1-yl]-2-(1-methylcyclopropyl)quinazolin-6-amine;methane;2-[[4-[4-(2-methoxyphenyl)piperidin-1-yl]-2-(1-methylcyclopropyl)quinazolin-6-yl]-methylamino]ethanol;4-[4-(2-methoxyphenyl)piperidin-1-yl]-N-methyl-2-(1-methylcyclopropyl)-N-propylquinazolin-6-amine
CID 162062816
6-bromo-2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazoline;tert-butyl N-piperidin-4-ylcarbamate;bis(carbon dioxide);2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]-N,N-dipropylquinazolin-6-amine;2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]-6-(4-methylpiperidin-1-yl)quinazoline;1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]piperidin-4-amine;ethyl 2-bromoacetate
CID 162225723
6-bromo-2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazoline;tert-butyl N-piperidin-4-ylcarbamate;bis(carbon dioxide);2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]-6-(4-methylpiperidin-1-yl)quinazoline;1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]-N,N-dipropylpiperidin-4-amine;1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]piperidin-4-amine;ethyl 2-bromoacetate
CID 163545112
8-bromo-2-butyl-N,1-bis[(2,4-dimethoxyphenyl)methyl]imidazo[4,5-c]quinolin-4-amine;tert-butyl 4-[2-butyl-1-[(2,4-dimethoxyphenyl)methyl]-4-[(2,4-dimethoxyphenyl)methylamino]imidazo[4,5-c]quinolin-8-yl]piperazine-1-carboxylate
CID 164047471

Frequently Asked Questions

What is the IUPAC name of 6-bromo-2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazoline;tert-butyl N-[(3R)-1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-yl]carbamate;tert-butyl N-[(3R)-pyrrolidin-3-yl]carbamate;(3R)-1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]-N,N-dimethylpyrrolidin-3-amine;(3R)-1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-amine?
The IUPAC name of 6-bromo-2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazoline;tert-butyl N-[(3R)-1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-yl]carbamate;tert-butyl N-[(3R)-pyrrolidin-3-yl]carbamate;(3R)-1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]-N,N-dimethylpyrrolidin-3-amine;(3R)-1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-amine (CID 158491247) is 6-bromo-2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazoline;tert-butyl N-[(3R)-1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-yl]carbamate;tert-butyl N-[(3R)-pyrrolidin-3-yl]carbamate;(3R)-1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]-N,N-dimethylpyrrolidin-3-amine;(3R)-1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-amine.
What is the SMILES notation for 6-bromo-2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazoline;tert-butyl N-[(3R)-1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-yl]carbamate;tert-butyl N-[(3R)-pyrrolidin-3-yl]carbamate;(3R)-1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]-N,N-dimethylpyrrolidin-3-amine;(3R)-1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-amine?
The canonical SMILES for 6-bromo-2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazoline;tert-butyl N-[(3R)-1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-yl]carbamate;tert-butyl N-[(3R)-pyrrolidin-3-yl]carbamate;(3R)-1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]-N,N-dimethylpyrrolidin-3-amine;(3R)-1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-amine is CC(C)(C)OC(=O)N[C@@H]1CCNC1.COc1ccccc1C1CCN(c2nc(C3CC3)nc3ccc(Br)cc23)CC1.COc1ccccc1C1CCN(c2nc(C3CC3)nc3ccc(N4CC[C@@H](N(C)C)C4)cc23)CC1.COc1ccccc1C1CCN(c2nc(C3CC3)nc3ccc(N4CC[C@@H](N)C4)cc23)CC1.COc1ccccc1C1CCN(c2nc(C3CC3)nc3ccc(N4CC[C@@H](NC(=O)OC(C)(C)C)C4)cc23)CC1.
What is the InChIKey of 6-bromo-2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazoline;tert-butyl N-[(3R)-1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-yl]carbamate;tert-butyl N-[(3R)-pyrrolidin-3-yl]carbamate;(3R)-1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]-N,N-dimethylpyrrolidin-3-amine;(3R)-1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-amine?
The InChIKey is HISKHXLFSPAPOS-ZHYCBDGJSA-N. The full InChI is InChI=1S/C32H41N5O3.C29H37N5O.C27H33N5O.C23H24BrN3O.C9H18N2O2/c1-32(2,3)40-31(38)33-23-15-18-37(20-23)24-11-12-27-26(19-24)30(35-29(34-27)22-9-10-22)36-16-13-21(14-17-36)25-7-5-6-8-28(25)39-4;1-32(2)23-14-17-34(19-23)22-10-11-26-25(18-22)29(31-28(30-26)21-8-9-21)33-15-12-20(13-16-33)24-6-4-5-7-27(24)35-3;1-33-25-5-3-2-4-22(25)18-10-13-31(14-11-18)27-23-16-21(32-15-12-20(28)17-32)8-9-24(23)29-26(30-27)19-6-7-19;1-28-21-5-3-2-4-18(21)15-10-12-27(13-11-15)23-19-14-17(24)8-9-20(19)25-22(26-23)16-6-7-16;1-9(2,3)13-8(12)11-7-4-5-10-6-7/h5-8,11-12,19,21-23H,9-10,13-18,20H2,1-4H3,(H,33,38);4-7,10-11,18,20-21,23H,8-9,12-17,19H2,1-3H3;2-5,8-9,16,18-20H,6-7,10-15,17,28H2,1H3;2-5,8-9,14-16H,6-7,10-13H2,1H3;7,10H,4-6H2,1-3H3,(H,11,12)/t2*23-;20-;;7-/m111.1/s1.
What are the key properties of 6-bromo-2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazoline;tert-butyl N-[(3R)-1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-yl]carbamate;tert-butyl N-[(3R)-pyrrolidin-3-yl]carbamate;(3R)-1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]-N,N-dimethylpyrrolidin-3-amine;(3R)-1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-amine?
6-bromo-2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazoline;tert-butyl N-[(3R)-1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-yl]carbamate;tert-butyl N-[(3R)-pyrrolidin-3-yl]carbamate;(3R)-1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]-N,N-dimethylpyrrolidin-3-amine;(3R)-1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-amine has a molecular weight of 2083.58 g/mol, XLogP of 22.02, 22 rotatable bonds, 4 hydrogen bond donors, and 26 hydrogen bond acceptors.
Where does this data come from?
All data for 6-bromo-2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazoline;tert-butyl N-[(3R)-1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-yl]carbamate;tert-butyl N-[(3R)-pyrrolidin-3-yl]carbamate;(3R)-1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]-N,N-dimethylpyrrolidin-3-amine;(3R)-1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-amine is sourced from PubChem (CID 158491247), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).